drugset / Trial / NCT03162588

Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya

NCT03162588

Phase 1/2 Completed 37 enrolled Ajou University School of Medicine
NaSingle-groupOpen-labelTreatment

Summary

In this study, the investigators aim to evaluate the indirect revascularization outcomes of a new combination therapy of multiple burrhole procedure with promotion of arteriogenesis by intravenous (IV) erythropoietin (EPO) pretreatment on Moyamoya patients with acute neurological presentation, and outline the clinical and vascular factors associated with revascularization through the burrholes.

Timeline

Start
2010-05-01
Primary completion
2016-09-30
Completion
2016-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject epoetin alfa Protein / enzyme biologic 40000 iu Intravenous